S2M Stock Overview
Develops, produces, and sells wound healing products for burns and chronic wounds in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
S2Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.041 |
| 52 Week High | SEK 0.33 |
| 52 Week Low | SEK 0.018 |
| Beta | 0.84 |
| 11 Month Change | -7.87% |
| 3 Month Change | -14.41% |
| 1 Year Change | -82.70% |
| 33 Year Change | -99.52% |
| 5 Year Change | -99.76% |
| Change since IPO | -99.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| S2M | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -3.5% | -6.8% | -6.7% |
| 1Y | -82.7% | -2.8% | 9.9% |
Return vs Industry: S2M underperformed the Swedish Medical Equipment industry which returned -0% over the past year.
Return vs Market: S2M underperformed the Swedish Market which returned 12.6% over the past year.
Price Volatility
| S2M volatility | |
|---|---|
| S2M Average Weekly Movement | 20.2% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.2% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: S2M's share price has been volatile over the past 3 months.
Volatility Over Time: S2M's weekly volatility has decreased from 29% to 20% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 17 | Petter Sivlér | www.s2m.se |
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover.
S2Medical AB (publ) Fundamentals Summary
| S2M fundamental statistics | |
|---|---|
| Market cap | SEK 11.29m |
| Earnings (TTM) | -SEK 17.12m |
| Revenue (TTM) | SEK 10.95m |
1.0x
P/S Ratio-0.7x
P/E RatioIs S2M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S2M income statement (TTM) | |
|---|---|
| Revenue | SEK 10.95m |
| Cost of Revenue | SEK 2.48m |
| Gross Profit | SEK 8.48m |
| Other Expenses | SEK 25.60m |
| Earnings | -SEK 17.12m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.062 |
| Gross Margin | 77.39% |
| Net Profit Margin | -156.32% |
| Debt/Equity Ratio | 0% |
How did S2M perform over the long term?
See historical performance and comparison